Company CVAbout Oxygenta Pharmaceutical Ltd 
Oxygenta Pharmaceutical Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990. The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited. Further, it was changed to Oxygenta Pharmaceutical Limited in FY 2021-22.
Company Coordinates
Company Details
Survey No 252/1 Aroor Village, Sadasivapet Mandal Medak Telangana : 502291
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 35.48 Cr
Number of Shares
3.55 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
21-May-2024
3.55
35.48
2000000
10
Preferential basis
03-May-2023
3.35
33.48
19282200
10
Warrant Conversion/Pref.allotment
30-Sep-2021
1.42
14.20
4000000
10
As Per Shareholding Pattern
30-Sep-2021
1.42
14.20
4000000
10
As Per Shareholding Pattern
12-Aug-2021
1.42
14.20
4000000
10
Preferential basis
01-Apr-2009
1.02
10.20
2500000
10
Conversion of Debt
01-Apr-2009
1.02
10.20
2500000
10
Conversion of Debt
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 3 Schemes (0.03%)
FIIs
Held by 0 FIIs
Promoter with highest holding
Virupaksha Organics Limited (55.9%)
Highest Public shareholder
Sravani Reddy Gantla (6.78%)
Individual Investors Holdings
38.9%
Board of Directors
Management
Designation
Remuneration
Sai Sudhakar Vankineni
Managing Director
12.0 lacs
D Vidya Sagar
Independent Director
0
Muralidhar R
Director (Technical)
0
Sangari Kondal Reddy
Independent Director
0
Padmaja Surapureddy
Independent Director
0
Kanuganti Raghavender Rao
Executive Director
0
Sravani Reddy Gantla
Additional Director
0
Bharath Reddy Guntuku
Additional Director
0
Dolly Mandhan
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Jobwork Income
2.76
33.89%
Jobwork Income
Jobwork Income
Stock DNARevenue and Profits:
Net Sales:
34 Cr
(Quarterly Results - Dec 2025)
Net Profit:
-5 Cr
Pharmaceuticals & Biotechnology
INR 218 Cr (Micro Cap)
NA (Loss Making)
33
0.00%
-1.95
48.39%
-5.85
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
